Aaron Ondrey

Direttore Finanziario/CFO presso ROCKET PHARMACEUTICALS, INC.

Patrimonio netto: 997 371 $ in data 31/05/2024

48 anni

Health Technology

Consumer Services

Posizioni attive di Aaron Ondrey

Società	Posizione	Inizio	Fine
ROCKET PHARMACEUTICALS, INC.	Direttore Finanziario/CFO	26/03/2024	-

Società	Posizione	Inizio	Fine
MIRATI THERAPEUTICS	Direttore Finanziario/CFO	08/09/2023	23/01/2024
MIRATI THERAPEUTICS	Corporate Officer/Principal	01/07/2022	08/09/2023
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/03/2010	01/11/2018

Case Western Reserve University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Director of Finance/CFO	2
Corporate Officer/Principal	2
Undergraduate Degree	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
ROCKET PHARMACEUTICALS, INC.	Health Technology
REGENERON PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.	Health Technology

Aziende private

Health Technology